01-26-2005: Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical Company and Starpharma have reached an agreement that provides DNT and Starpharma with ownership or access to the world's broadest patent portfolio in the field of dendrimers, and establishes the companies as leading providers of market-validated nanotechnology with near-term, tangible commercial applications.
Under terms of the deal, Dow will assign its entire intellectual property portfolio and associated royalties in the field of dendrimers (196 patents comprising 41 patent families) to DNT in exchange for a significant equity stake in DNT. Starpharma, which already held a 42% interest in DNT, will make an additional cash equity investment in DNT in exchange for exclusive rights to DNT and former Dow intellectual property for polyvalent, dendrimer-based pharmaceutical applications.
"As part of this agreement, Dow has assigned all of our extensive intellectual property in this field to DNT," explained Mike Pirc, manager of intellectual property, The Dow Chemical Company. "This move consolidates a great amount of the important intellectual property in the dendrimer field into one company. It will be very positive for developing the applications and further demonstrating the value of this technology."
Dendrimers are a new class of nanostructures with physical properties that make them ideal vehicles for targeting diseases and delivering drugs to fight them. Dendrimer technology was first developed at Dow when DNT founder Donald Tomalia was a Dow employee.
Watchlist
This is where you can add this news to your personal favourites
At the 2012 American Cleaning Institute (ACI) Annual Meeting and Industry Convention, January 30 through February 4 in Orlando, Florida, Henkel recognized four outstanding suppliers for their excellent cooperation. The “Henkel Sustainability Award”, which is presented for the first time, wa ... more
Dow Home & Personal Care, a business unit of The Dow Chemical Company received the “Best Innovation Contributor 2011” award from Henkel Laundry & Home Care at the 2012 American Cleaning Institute (ACI) Annual Meeting and Industry Convention, Jan. 30 to Feb. 4, 2012 in Orlando, Florida. Ever ... more
The Dow Chemical Company announced that the SCG-Dow Group, a joint venture between Dow and Siam Cement Group, has finalized the start-up of its new propylene oxide (PO) facility in Thailand by successfully completing its full capacity performance test. Dow reached a key milestone in Octobe ... more
With annual sales of $58 billion in 2008 and 46,000 employees worldwide, Dow is a diversified chemical company that combines the power of science and technology with the " Human Element ” to constantly improve what is essential to human progress. The Company delivers a broad range of produ ... more
Dendritic NanoTechnologies Inc. (DNT) announced a patent-pending development: a new family of scalable, precision dendrimer nanostructures. The new technology, developed by DNT, is called Priostar(TM) and offers a significant advantage over other precision nanostructures by reducing the com ... more
Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical Company and Starpharma have reached an agreement that provides DNT and Starpharma with ownership or access to the world's broadest patent portfolio in the field of dendrimers, and establishes the companies as leading providers of marke ... more
The Forbes/Wolfe Nanotech Report, a leading investor newsletter analysing advancements in the nanotechnology industry, has added Starpharma's American Depositary Receipts (ADRs), to its "Nanosphere" list of leading nanotechnology stocks.
The Forbes/Wolfe Nanotech Report describes the Nanos ... more
Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical Company and Starpharma have reached an agreement that provides DNT and Starpharma with ownership or access to the world's broadest patent portfolio in the field of dendrimers, and establishes the companies as leading providers of marke ... more